CanaFarma Hemp Products Corp. has partnered with APeT BV to develop novel Hemp-based cannabinoid, drug and nutritional supplement delivery methods via its FLOTEXC patented technology. FLOTEXC is a unique, patented, floating technology designed for safer and more effective delivery of active ingredients. FLOTEXC is a GastroRetentive Drug Delivery System ("GRDDS"), whereby active ingredients are delivered in a time released manner via a capsule that "floats" within the stomach. FLOTEXC has excellent floating capacity of at least 24 hours, whereby buoyancy increases in time thanks to the steady floating chamber. The collaboration between the two companies will use the APeT BV FLOTEXC technology to create novel approaches to infusing Hemp-based cannabinoids into a safer, self-repairing, better performing, gastro-retentive, controlled-release delivery platform for pharmaceuticals and nutraceuticals. Focus will be on anti-viral, immune boosting and anti-aging formulations. Many patients are suffering from side effects from, or lack of efficacy of, their medication(s). Additionally, therapy compliance challenges such as too many pills spread over different hours of intake per day, can lead to skipping/forgetting to take the right amount of medication at the right time, or stopping the therapy all together. Canafarma and APeT's use of the FLOTEXC technology will be designed with the objective of resolving many of these problems.